Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anton Oseledchyk

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|September 20, 2015
Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian CancerAnton Oseledchyk, Oliver Zivanovic
ACS Nano|December 20, 2016
Folate-Targeted Surface-Enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detection of Microscopic Ovarian CancerAnton Oseledchyk, Chrysafis Andreou, Matthew A Wall, et al.
Cancers|October 28, 2023
Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane-PLD versus PLD-Taxane in Patients with Metastatic Breast CancerTill Wallrabenstein, Anton Oseledchyk, Eveline Daetwyler, et al.
Advanced Functional Materials|November 18, 2017
MUC1 Aptamer Targeted SERS NanoprobesSuchetan Pal, Stefan Harmsen, Anton Oseledchyk, et al.
Journal of Visualized Experiments : Jove|April 9, 2019
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor TargetingChrysafis Andreou, Anton Oseledchyk, Fay Nicolson, et al.
BMC Pregnancy and Childbirth|January 13, 2016
Approach to the sonographic evaluation of fetal ventriculomegaly at 11 to 14 weeks gestationGwendolin Manegold-Brauer, Anton Oseledchyk, Anne Floeck, et al.
Diagnostics (Basel, Switzerland)|January 11, 2024
Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORxElena Diana Chiru, Anton Oseledchyk, Andreas Schoetzau, et al.
Nanoscale|December 20, 2016
Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastasesTapas R Nayak, Chrysafis Andreou, Anton Oseledchyk, et al.
Cancer Medicine|April 19, 2018
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort studyAnton Oseledchyk, Renee L Gennarelli, Mario M Leitao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|September 20, 2015
Intraoperative Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian CancerAnton Oseledchyk, Oliver Zivanovic
ACS Nano|December 20, 2016
Folate-Targeted Surface-Enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detection of Microscopic Ovarian CancerAnton Oseledchyk, Chrysafis Andreou, Matthew A Wall, et al.
Cancers|October 28, 2023
Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane-PLD versus PLD-Taxane in Patients with Metastatic Breast CancerTill Wallrabenstein, Anton Oseledchyk, Eveline Daetwyler, et al.
Advanced Functional Materials|November 18, 2017
MUC1 Aptamer Targeted SERS NanoprobesSuchetan Pal, Stefan Harmsen, Anton Oseledchyk, et al.
Journal of Visualized Experiments : Jove|April 9, 2019
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor TargetingChrysafis Andreou, Anton Oseledchyk, Fay Nicolson, et al.
BMC Pregnancy and Childbirth|January 13, 2016
Approach to the sonographic evaluation of fetal ventriculomegaly at 11 to 14 weeks gestationGwendolin Manegold-Brauer, Anton Oseledchyk, Anne Floeck, et al.
Diagnostics (Basel, Switzerland)|January 11, 2024
Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORxElena Diana Chiru, Anton Oseledchyk, Andreas Schoetzau, et al.
Nanoscale|December 20, 2016
Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastasesTapas R Nayak, Chrysafis Andreou, Anton Oseledchyk, et al.
Cancer Medicine|April 19, 2018
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort studyAnton Oseledchyk, Renee L Gennarelli, Mario M Leitao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.
Pageof 3